Increased p53 activity does not accelerate telomere-driven ageing.
about
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerRegulation of glucose metabolism by p53: emerging new roles for the tumor suppressorTwo faces of p53: aging and tumor suppressionTelomeres in aging and disease: lessons from zebrafishTelomeres and telomerase as therapeutic targets to prevent and treat age-related diseasesTP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephantsTissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53.Telomere shortening reduces regenerative capacity after acute kidney injury.p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo.Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status.Removing all obstacles: a critical role for p53 in promoting tissue renewalTelomeres in cancer and ageing.Increased Arf/p53 activity in stem cells, aging and cancer.Regulation of senescence in cancer and aging.The longest telomeres: a general signature of adult stem cell compartments.Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.Cellular senescence and organismal aging.Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres.A metabolic signature predicts biological age in mice.Aging by epigenetics--a consequence of chromatin damage?REGγ deficiency promotes premature aging via the casein kinase 1 pathway.TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis.A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAsA genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance.The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior.Jun dimerization protein 2 controls senescence and differentiation via regulating histone modification.The p53 tumor suppressor protein regulates hematopoietic stem cell fate.How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.Battling cancer on many fronts. Meeting on New Battlefields in Human Cancer--Attacking in Many Fronts.Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16Ink4a-pRb and Arf-p53 pathways.Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
P2860
Q24615809-E9DF3CEC-9008-437A-AFA1-AA37AA008763Q24631421-E829706E-7C37-4D59-8C14-3D87902D7DFEQ24681014-18B846DA-6ECC-460B-9D75-C6D1B4A253C8Q26740023-2501437F-F802-44D7-9E68-113FC1AB7233Q26747735-01FE2B2A-F04A-4E38-8ED4-22E00F099528Q28597702-40A74827-ECD4-4B0D-8887-E701DDAA9C28Q33661151-25082909-149E-4F93-88A3-EBCB642726BAQ33711300-555A4E85-C3EF-4D5D-8480-D230080EA4F5Q33809750-8F7063DE-B7C6-4088-B5E8-060EB421C2E9Q33949558-C0F2C431-B070-4029-80A5-0C4FD50AC69CQ34306322-A707CD2B-9C2A-4F8B-A45C-C6B7207E7D20Q34402746-4F956404-71AD-4AEC-823C-9E33C02E3C2FQ34549629-6D7185F3-C1D7-4020-9D70-0A290199C978Q34665706-5B8934F9-37EC-4E50-A2A9-5370CF383DE6Q34751815-4E08F42B-D9B5-450F-A2AC-A0396AC05A77Q35188247-6CB979E9-9FD1-43FA-A05C-7186EF049099Q35589168-5E1A0AD4-8E10-4FB1-B344-D1B51F7A1847Q35795073-D6F38B72-5C96-45EB-82BD-3C6E855CA46DQ35815320-6E0B4689-8EA4-4F99-B64F-BC002810BAFCQ36119587-2D146066-5045-409E-9E42-A08E2070CEFCQ36553679-FE5187BE-7FEC-443F-831B-933DADE9AE2BQ36766079-50CFF069-78BF-4094-AC2D-5C63E69F6659Q36990873-A6D70B21-DCFF-49F3-9297-5D9089A31B7EQ37110604-40EABCC5-3969-4FB9-BED3-8154738D9DF5Q37293050-014299E4-4D24-414D-8273-1FFA656AF366Q37422064-D63441A5-F429-40F3-8CE1-01B6CC1EDA7EQ37597839-B7D5498C-24E6-4284-83FF-B3D5878F5329Q37825439-F476F355-DAAD-41F2-9C67-5BB6EB78A24FQ37887629-D903BDB6-9299-47C5-B43A-8362247835ADQ38122351-44C10168-C196-4A39-98EA-1B9B4B1F04EAQ42427012-6D7ED081-B81A-496C-98C3-366A91916367Q45373113-63677320-94B4-4FF2-A4BE-E2CE415D7FE7Q51304904-C137FEDA-50A6-4E99-8C91-69FA26A5D30DQ58775287-83E0AE9A-9A65-4C92-ABE8-5E6E8CB3FA2F
P2860
Increased p53 activity does not accelerate telomere-driven ageing.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased p53 activity does not accelerate telomere-driven ageing.
@ast
Increased p53 activity does not accelerate telomere-driven ageing.
@en
Increased p53 activity does not accelerate telomere-driven ageing.
@nl
type
label
Increased p53 activity does not accelerate telomere-driven ageing.
@ast
Increased p53 activity does not accelerate telomere-driven ageing.
@en
Increased p53 activity does not accelerate telomere-driven ageing.
@nl
prefLabel
Increased p53 activity does not accelerate telomere-driven ageing.
@ast
Increased p53 activity does not accelerate telomere-driven ageing.
@en
Increased p53 activity does not accelerate telomere-driven ageing.
@nl
P2093
P2860
P356
P1433
P1476
Increased p53 activity does not accelerate telomere-driven ageing.
@en
P2093
Antonia Tomás-Loba
Isabel García-Cao
Juan Martín-Caballero
Juana M Flores
Marta García-Cao
Peter Klatt
P2860
P304
P356
10.1038/SJ.EMBOR.7400667
P577
2006-03-31T00:00:00Z